The psychedelic medicine community has lost one of its great figures as Dr. Roland Griffiths has passed away. The post Honoring Roland Griffiths: Psychedelic...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Cybin Inc. (NYSE AMERICAN:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of the...
The FDA has issued a warning letter regarding the use of ketamine outside of FDA-approved conditions. The post FDA Issues Warning Letter for Ketamine...
Cybin shareholders approve the acquisition of Small Pharma with 99.4% of the vote. The post Cybin Shareholders Approve Acquisition of Small Pharma appeared...
Research has shown ketamine to have rapid antidepressant effects. The post Ketamine Clinics Hope to ‘Open New Doors’ for Patients with Severe Depression...
Hear from experienced educators and operators on how to navigate the demanding need for education in the space of psychedelic training and therapy. Participants...
Welcome to the fourth season of the Psychedelic Invest Podcast! It’s great to be back! On the season premiere episode, host Bruce Eckfeldt is joined...
Atai Life Sciences AG (Nasdaq: ATAI) clearly believes in the medical technology from IntelGenx Technologies Corp. (OTC: IGXT) as the company has leaned...